Resolutions at the Extraordinary General Meeting in Medivir on 2 February 2017
Voluntary redemption programme The Extraordinary General Meeting in Medivir Aktiebolag (publ) on 2 February 2017 resolved, in accordance with the Board of Directors' proposal, on a voluntary redemption programme comprising reduction of the share capital for repayment to the shareholders, and bonus issue without issuance of new shares. The redemption programme will be effected by redemption of a maximum of 6,738,655 shares, whereof 151,589 series A shares and 6,587,066 series B shares. For each share in the company, the shareholder receives one redemption right. Four (4) redemption